廣告
香港股市 已收市

  • 恒指

    18,963.68
    +425.87 (+2.30%)
     

  • 國指

    6,718.86
    +158.19 (+2.41%)
     

  • 上證綜指

    3,154.55
    +0.23 (+0.01%)
     

  • 滬深300

    3,666.28
    +1.72 (+0.05%)
     

  • 美元

    7.8132
    -0.0006 (-0.01%)
     

  • 人民幣

    0.9243
    +0.0009 (+0.10%)
     

  • 道指

    39,512.84
    +125.08 (+0.32%)
     

  • 標普 500

    5,222.68
    +8.60 (+0.16%)
     

  • 納指

    16,340.87
    -5.40 (-0.03%)
     

  • 日圓

    0.0499
    -0.0001 (-0.18%)
     

  • 歐元

    8.4127
    -0.0110 (-0.13%)
     

  • 英鎊

    9.7820
    -0.0020 (-0.02%)
     

  • 紐約期油

    78.20
    -1.06 (-1.34%)
     

  • 金價

    2,366.90
    +26.60 (+1.14%)
     

  • Bitcoin

    60,991.50
    +9.06 (+0.01%)
     

  • CMC Crypto 200

    1,263.36
    -94.65 (-6.97%)
     

HCA (HCA) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2 分鐘文章

For the quarter ended March 2024, HCA Healthcare (HCA) reported revenue of $17.34 billion, up 11.2% over the same period last year. EPS came in at $5.36, compared to $4.93 in the year-ago quarter.

The reported revenue represents a surprise of +2.93% over the Zacks Consensus Estimate of $16.84 billion. With the consensus EPS estimate being $5.01, the EPS surprise was +6.99%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

廣告

Here is how HCA performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue per Equivalent Admission: $17,666 compared to the $17,449.01 average estimate based on four analysts.

  • Equivalent Admissions: 981.52 million compared to the 964.89 million average estimate based on four analysts.

  • Equivalent Patient Days: 4,867.79 thousand versus the three-analyst average estimate of 4,758.83 thousand.

  • Number of hospitals: 188 compared to the 187 average estimate based on three analysts.

  • Licensed Beds at End of Period: 49,724 versus 49,285 estimated by two analysts on average.

  • Same Facility - Equivalent Admissions: 960.77 thousand versus 949.98 thousand estimated by two analysts on average.

  • Average Length of Stay: 5 versus 5 estimated by two analysts on average.

  • Number of freestanding outpatient surgery centers: 121 versus 124 estimated by two analysts on average.

  • Patient Days: 2,781.6 Days versus the two-analyst average estimate of 2,708.5 Days.

  • Admissions: 560.87 million versus the two-analyst average estimate of 548.95 million.

View all Key Company Metrics for HCA here>>>

Shares of HCA have returned -5.8% over the past month versus the Zacks S&P 500 composite's -3.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research